Quick Takeaways
- Invus Global Management, LLC filed SCHEDULE 13G for Olema Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share (OLMA).
- Disclosed ownership: 5.1%.
- Date of event: 16 Mar 2026.
Invus Global Management, LLC - 16 Mar 2026 SCHEDULE 13G Report for Olema Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share (OLMA)
- Filing Manager
- Invus Global Management, LLC
- Reporting Manager
- Raymond Debbane
- Symbol
- OLMA
- Shares outstanding
- 87,489,196 shares
- Disclosed Ownership
- 4,461,949 shares
- Ownership
- 5.1%
- Form type
- SCHEDULE 13G
- Filing time
- 20 Mar 2026, 10:37:43 UTC
- Date of event
- 16 Mar 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"Invus Global Management, LLC disclosed 5.1% ownership in Olema Pharmaceuticals, Inc. Common Stock, par value $0.0001 per share (OLMA) on 16 Mar 2026."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 20 Mar 2026, 10:37.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (8)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Invus Public Equities, L.P. | 4.5% | 3,898,500 | 3,898,500 | 0 | /s/ Raymond Debbane | Raymond Debbane, President of Invus Public Equities Advisors, LLC, its general partner | |
| Invus Public Equities Advisors, LLC | 4.5% | 3,898,500 | 3,898,500 | 0 | /s/ Raymond Debbane | Raymond Debbane, President | |
| Invus Global Management, LLC | 4.5% | 3,898,500 | 3,898,500 | 0 | /s/ Raymond Debbane | Raymond Debbane, President | |
| Siren, L.L.C. | 4.5% | 3,898,500 | 3,898,500 | 0 | /s/ Raymond Debbane | Raymond Debbane, President | |
| Avicenna Life Sci Master Fund LP | 0.6% | 563,449 | 563,449 | 0 | /s/ Raymond Debbane | Raymond Debbane, Chief Executive Officer of Avicenna Life Sci Master GP LLC, its general partner | |
| Avicenna Life Sci Master GP LLC | 0.6% | 563,449 | 563,449 | 0 | /s/ Raymond Debbane | Raymond Debbane, Chief Executive Officer | |
| Ulys, L.L.C. | 0.6% | 563,449 | 563,449 | 0 | /s/ Raymond Debbane | Raymond Debbane, President | |
| Raymond Debbane | 5.1% | 4,461,949 | 4,461,949 | 0 | /s/ Raymond Debbane | Raymond Debbane |